The AstraZeneca COVID-19 vaccine is suspected of being linked to a small number of deep vein thrombosis (DVT) cases, which recently emerged within Europe as millions of people received vaccinations. This led several countries ...
Mathematics
Apr 27, 2021
5
359
By cracking open a cellular membrane, Northwestern University synthetic biologists have discovered a new way to increase production yields of protein-based vaccines by five-fold, significantly broadening access to potentially ...
Biotechnology
Apr 22, 2021
0
60
New research has for the first time compared images of the protein spikes that develop on the surface of cells exposed to the Oxford-AstraZeneca vaccine to the protein spike of the SARS-CoV-19 coronavirus. The images show ...
Cell & Microbiology
Apr 7, 2021
1
623
A new, detailed model of the surface of the SARS-CoV-2 spike protein reveals previously unknown vulnerabilities that could inform development of vaccines. Mateusz Sikora of the Max Planck Institute of Biophysics in Frankfurt, ...
Molecular & Computational biology
Apr 1, 2021
0
253
Scientists have developed vaccines for COVID-19 with record speed. The first two vaccines widely distributed in the U.S. are mRNA-based and require ultracold storage (-70 C for one and -20 C for the other). Now, researchers ...
Materials Science
Mar 31, 2021
0
17
Researchers from Massey University and the University of Warwick have found that non-dairy stock farmers are just as likely to get infected with leptospirosis as dairy farmers, proving the disease is no longer dominant in ...
Cell & Microbiology
Feb 22, 2021
0
14
A mutation in the spike protein of SARS-CoV-2—one of several genetic mutations in the concerning variants that have emerged in the United Kingdom, South Africa, and Brazil—makes the virus up to eight times more infectious ...
Cell & Microbiology
Feb 17, 2021
2
2210
Messenger RNA (mRNA) vaccines to prevent COVID-19 have made headlines around the world recently, but scientists have also been working on mRNA vaccines to treat or prevent other diseases, including some forms of cancer. Now, ...
Bio & Medicine
Feb 17, 2021
1
1286
As the opioid epidemic raged on with an even greater force during COVID-19, the Scripps Research laboratory of chemist Kim Janda, Ph.D., has been working on new therapeutic interventions that may be able to prevent the bulk ...
Biochemistry
Feb 4, 2021
1
653
Researchers have used plants to produce virus-like particles (VLPs) of the dengue virus in a potential first step towards novel vaccines against the growing threat.
Biotechnology
Dec 3, 2020
0
39
